Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Sheng Ai

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Current Drug Targets|March 5, 2015
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic CancersElizabeth F Krakow, Hui-Sheng Ai, Brian Shaffer, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 23, 2004
[Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study]Jian-Jie Li, Yi Zhang, Ming-Wei Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
[Comparison of efficiencies mobilizing stem cells into peripheral blood in healthy donors by different schemes with G-CSF]Dan-Hong Wang, Mei Guo, Chang-Lin Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2013
[Haploidentical nonmyeloablative allogeneic peripheral blood stem cell transplantation for treatment of refractory or relapsed leukemia: long-term follow-up]Zheng Dong, Kai-xun Hu, Chang-lin Yu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 10, 2003
[Cyclosporine A and mycophenolate mofetile as prophylactics for GVHD in a murine model of H-2 haploidentical nonmyeloablative bone marrow transplantation]Xin Li, Yi Zhang, Wang-Jun Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 26, 2014
[Risk factors analysis of cytomegalovirus infection after nonmyeloablative allogeneic peripheral blood stem cell transplantation]Yong-Ping Zhang, Kai-Xun Hu, Qi-Yun Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 1, 2013
[Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance]Fang-Fang Xiao, Kai-Xun Hu, Mei Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2013
[Prophylactic G-CSF mobilized donor lymphocytes infusion after non-myeloablative stem cell transplantation prevents relapse in patients with high-risk leukemia]Hong-xia Zhao, Wan-jun Sun, Jie Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 15, 2003
[Diagnosis and treatment of invasive pulmonary aspergillosis in malignant hematological diseases-3 cases reported]Jian-Hui Qiao, Wan-Jun Sun, Chang-Lin Yu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 3, 2013
[Different changes of serum cytokines following HLA-identical and HLA haploidentical non-myeloablative allogeneic hematopoietic stem cell transplantation]Yue-Ying Zhao, Yan Kang, Qi-Yun Sun, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Current Drug Targets|March 5, 2015
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic CancersElizabeth F Krakow, Hui-Sheng Ai, Brian Shaffer, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 23, 2004
[Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study]Jian-Jie Li, Yi Zhang, Ming-Wei Zhang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 11, 2007
[Comparison of efficiencies mobilizing stem cells into peripheral blood in healthy donors by different schemes with G-CSF]Dan-Hong Wang, Mei Guo, Chang-Lin Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2013
[Haploidentical nonmyeloablative allogeneic peripheral blood stem cell transplantation for treatment of refractory or relapsed leukemia: long-term follow-up]Zheng Dong, Kai-xun Hu, Chang-lin Yu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 10, 2003
[Cyclosporine A and mycophenolate mofetile as prophylactics for GVHD in a murine model of H-2 haploidentical nonmyeloablative bone marrow transplantation]Xin Li, Yi Zhang, Wang-Jun Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 26, 2014
[Risk factors analysis of cytomegalovirus infection after nonmyeloablative allogeneic peripheral blood stem cell transplantation]Yong-Ping Zhang, Kai-Xun Hu, Qi-Yun Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 1, 2013
[Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance]Fang-Fang Xiao, Kai-Xun Hu, Mei Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2013
[Prophylactic G-CSF mobilized donor lymphocytes infusion after non-myeloablative stem cell transplantation prevents relapse in patients with high-risk leukemia]Hong-xia Zhao, Wan-jun Sun, Jie Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 15, 2003
[Diagnosis and treatment of invasive pulmonary aspergillosis in malignant hematological diseases-3 cases reported]Jian-Hui Qiao, Wan-Jun Sun, Chang-Lin Yu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 3, 2013
[Different changes of serum cytokines following HLA-identical and HLA haploidentical non-myeloablative allogeneic hematopoietic stem cell transplantation]Yue-Ying Zhao, Yan Kang, Qi-Yun Sun, et al.
Pageof 8